Literature DB >> 31272243

Inspiratory Constraints and Ventilatory Inefficiency Are Superior to Breathing Reserve in the Assessment of Exertional Dyspnea in COPD.

J Alberto Neder1, Danilo C Berton1, Mathieu Marillier1, Anne-Catherine Bernard1, Denis E O'Donnell1.   

Abstract

Combining measurements of impaired lung mechanics (inspiratory constraints) with an index of increased respiratory stimuli to metabolic demand (poor ventilatory efficiency) might enhance the ability of cardiopulmonary exercise testing (CPET) in exposing a mechanistic role for ventilation on exertional dyspnea in COPD. In addition to the standard approach to suggest ventilatory limitation to exercise - a low breathing reserve (1-(peak ventilation (V̇E)/maximal voluntary ventilation × 100 < 20%) - we assessed the presence of critical inspiratory constraints (end-inspiratory lung volume (EILV)/total lung capacity (TLC) ≥ 0.9) and ventilatory inefficiency (V̇E/CO2 output (V̇CO2) nadir > 34) in 288 patients with mild to very severe COPD (FEV1 ranging from 18 to 121% predicted). We found that ∼50% of the patients with preserved breathing reserve developed critical inspiratory constraints. A low breathing reserve was weakly related to a lower peak O2 uptake (V̇O2) and/or a higher dyspnea burden; for instance, patients with low breathing reserve but without critical inspiratory constraints had similar dyspnea and peak V̇O2 than those with preserved breathing reserve (p > 0.05). In contrast, critical inspiratory constraints and ventilatory inefficiency were strongly associated with a negative outcome (likelihood ratio = 42.3 and 47.7, respectively; p < 0.001). A multiple logistic regression analysis revealed that only EILV/TLC ≥ 0.9 and V̇E/V̇CO2 nadir >34 predicted a severely reduced peak V̇O2 due to a high dyspnea burden (p < 0.001). Measurements of dynamic mechanical constraints and ventilatory inefficiency during incremental CPET are key to determine the impact of COPD on dyspnea and exercise tolerance across the spectrum of disease severity.

Entities:  

Keywords:  Dyspnea; cardiopulmonary exercise testing; lung mechanics; ventilatory efficiency

Mesh:

Year:  2019        PMID: 31272243     DOI: 10.1080/15412555.2019.1631776

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  6 in total

1.  Value of Cardiopulmonary Exercise Testing in the Prognosis Assessment of Chronic Obstructive Pulmonary Disease Patients: A Retrospective, Multicentre Cohort Study.

Authors:  Ralf Ewert; Anne Obst; Andreas Mühle; Michael Halank; Jörg Winkler; Bernd Trümper; Gerhard Hoheisel; Andreas Hoheisel; Mark Wiersbitzky; Alexander Heine; Alexander Maiwald; Sven Gläser; Beate Stubbe
Journal:  Respiration       Date:  2021-11-19       Impact factor: 3.966

2.  Pulmonology approach in the investigation of chronic unexplained dyspnea.

Authors:  Danilo Cortozi Berton; Nathalia Branco Schweitzer Mendes; Pedro Olivo-Neto; Igor Gorski Benedetto; Marcelo Basso Gazzana
Journal:  J Bras Pneumol       Date:  2021-02-08       Impact factor: 2.624

3.  Clinical Interpretation of Cardiopulmonary Exercise Testing: Current Pitfalls and Limitations.

Authors:  J Alberto Neder; Devin B Phillips; Mathieu Marillier; Anne-Catherine Bernard; Danilo C Berton; Denis E O'Donnell
Journal:  Front Physiol       Date:  2021-03-18       Impact factor: 4.566

4.  Phenotyping Cardiopulmonary Exercise Limitations in Chronic Obstructive Pulmonary Disease.

Authors:  Jinelle Gelinas; Megan Harper; John Sasso; Stephen Wright; Bernie Melzer; Gloria Agar; Jordan Guenette; Gregory duManoir; Michael Roman; J Douglass Rolf; Neil Eves
Journal:  Front Physiol       Date:  2022-02-15       Impact factor: 4.566

Review 5.  Low Cardiorespiratory Fitness Post-COVID-19: A Narrative Review.

Authors:  Fabian Schwendinger; Raphael Knaier; Thomas Radtke; Arno Schmidt-Trucksäss
Journal:  Sports Med       Date:  2022-09-17       Impact factor: 11.928

6.  Does Regular Physical Activity Mitigate the Age-Associated Decline in Pulmonary Function?

Authors:  Johannes Burtscher; Grégoire P Millet; Hannes Gatterer; Karin Vonbank; Martin Burtscher
Journal:  Sports Med       Date:  2022-02-03       Impact factor: 11.928

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.